BC-05

BC-05 structure	Common Name	BC-05
	CAS Number	2260717-73-3	Molecular Weight	464.27
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₁H₂₉BN₂O₉	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of BC-05

BC-05 is an orally active and potent inhibitor of CD13 and proteasome. BC-05 has an IC50 value of 0.13 μM for human CD13 and an IC50 value of 1.39 μM for the 20S proteasome. BC-05 can be used in multiple myeloma research[1].

Name	BC-05

Description	BC-05 is an orally active and potent inhibitor of CD13 and proteasome. BC-05 has an IC50 value of 0.13 μM for human CD13 and an IC50 value of 1.39 μM for the 20S proteasome. BC-05 can be used in multiple myeloma research[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others Signaling Pathways >> Metabolic Enzyme/Protease >> Proteasome
References	[1]. Zhang J, et al. Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer. Molecules. 2023 Aug 30;28(17):6343.

Molecular Formula	C₂₁H₂₉BN₂O₉
Molecular Weight	464.27

Dichloromethane
CAS#:75-09-2

Polyacrylic acid
CAS#:9003-01-4

sodium carbonate
CAS#:497-19-8

Silicon dioxide
CAS#:7631-86-9

Triethanolamine
CAS#:102-71-6

Demeton
CAS#:126-75-0

Water
CAS#:7732-18-5

4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9

Diclofenac sodium
CAS#:15307-79-6

Budesonide
CAS#:51372-29-3

BC-05

Use of BC-05

Names

BC-05 Biological Activity

Chemical & Physical Properties